<DOC>
	<DOCNO>NCT02064764</DOCNO>
	<brief_summary>The purpose clinical study evaluate feasibility perform renal nerve denervation pulmonary vein isolation patient intent characterize safety effectiveness paroxysmal persistent atrial fibrillation population hypertension . To assess safety , study measure occurrence composite safety endpoint , assess effectiveness , study measure freedom chronic treatment failure minimum six month follow-up .</brief_summary>
	<brief_title>Renal Nerve Denervation Patients With Hypertension Paroxysmal Persistent Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Key Drug refractory recurrent symptomatic paroxysmal persistent atrial fibrillation Officebased systolic blood pressure ≥150 mm Hg base despite treatment 2 antihypertensive medication different class ( one must diuretic ) Age 18 year 80 year old . Key Renal artery anatomy ineligible treatment include : Lacks least one renal artery kidney ≥3 mm diameter minimum treatable length per Spyral Instructions Use , Renal artery stenosis ( &gt; 50 % ) renal artery aneurysm either renal artery , A history prior renal artery intervention include balloon angioplasty stenting , Renal artery contain calcification allow least four radio frequency ablation deliver , Diffuse fibromuscular dysplasia ( FMD ) FMD allow least four radio frequency ablation deliver ; FMD define visible bead artery angiography , Unilateral kidney . Estimated Glomerular Filtration Rate &lt; 30 mL/min/1.73m2 . Pregnant , nurse planning pregnant . ( Female participant childbearing potential must negative serum urine human chorionic gonadotropin ( hCG ) pregnancy test prior angiography ) . Currently enrol plan participate potentially confound drug device trial course study . Coenrollment concurrent study allow documented preapproval obtain Medtronic study manager .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>